TORONTO, July 26, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare technology and services company, is pleased to provide an update on the Company’s business and operations.
The Company’s primary business activities are conducted through its wholly owned subsidiary, Collection Sites LLC, which has over 190 employees and has built a network of 22 mobile COVID-19 testing centers across the United States, including in the states of California, Texas, Colorado, Nevada, Indiana and Florida. Each site is a modular pod “cube” licensed by a lab certified by the United States Government Department of Health and Human Services.
COVID-19 testing remains an important detection and tool to fight the ongoing coronavirus pandemic. David Preiner, CEO of Medivolve commented “Governments around the world have lifted restrictions and reduced coronavirus tracking as they grapple with pandemic fatigue, however new waves of the virus demonstrate that COVID-19 is nowhere near over. Medivolve is proud of its work to continue to offer COVID testing to citizens throughout the United States.”
The Company is considering expanding its network of mobile COVID-19 testing centers in anticipation of another possible COVID wave fueled by the BA.4 and BA.5 subvariants. Medivolve continues to look for opportunities to open more testing centers in underserved neighborhoods.
Medivolve, Inc. (NEO: MEDV; OTC: COPRF; FRA: 4NC) is a healthcare technology company that seeks to reinvent the US healthcare system by leveraging a bespoke telehealth platform, a clinical diagnostic network, and a data-driven AI framework to improve patient care.
The company was born out of the healthcare crisis; to rethink, relearn and ultimately, reimagine a better way for the healthcare system to operate. Our network of retail collection sites play an important role in recovery by giving all Americans access to fast, accurate, and inexpensive clinical services when and where they need it. These centers will also play a pivotal role in diagnostic testing, vaccinations, and other point-of-care services. We are building disruptive technologies to make it easier and faster to identify, treat, and prevent medical issues. In doing so, we are working to give patients a holistic and empowered view of their personal health.
Our long-term mission is to permanently fix systemic issues in the nation's fragmented, overly complex, and expensive healthcare system. Medivolve's next phase of growth is about pivoting the model and putting the pieces together to build a profitable, SaaS-based health-tech company. We are bringing data-driven clinical diagnostics, physician recommendations, and prescription medications directly to people, all powered by a singular, streamlined technology network. Our team is united by a powerful, singular purpose: harnessing the transformative power of technology to create healthier lives.
Underpinned by a bespoke, AI-driven platform, we're developing a stealth system that constantly gets smarter, takes the guesswork out of diagnostics, and flags critical health issues immediately to deliver an unparalleled level of personalization for each patient. We are determined to push the boundaries of what's possible—not just for our business and our shareholders, but for physicians and patients, and for the future of healthcare. We are striving to achieve a continuity of care never seen before, a game changer for our business and for patients in the communities we serve.
For investing inquiries, please contact: David Preiner, firstname.lastname@example.org, 702-990-3737.
Cautionary Note Regarding Forward-looking Information
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the Company’s business and operations, the future outlook for COVID-19 and plans to expand the Company’s mobile testing network. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance, or achievements of the Company, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
NEITHER THE NEO EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
STORY: The EU has approved a monkeypox vaccine made by biotech firm Bavarian Nordic.That's according to the Danish firm on Monday (July 25).It said the European Commission would allow its Imvanex shot to be marketed as protection against the disease.Previously the EU has only allowed it to be shown as a treatment for smallpox.The decision comes just a day after the World Health Organization called the rapidly-spreading monkeypox a global health emergency.The vaccine has already been approved in the United States and Canada.Bavarian said the development of Imvanex was made possible by big investment from the U.S. government over the past two decades.The news cheered investors.Bavarian's share price rose 3% after the update.Its stock is up more than 120% over the last three months, driven by strong demand for the monkeypox vaccine.
Take travel-rewards credit cards, which consumers use to help pay for business travel and vacations. According to a new ValuePenguin survey of 1,000 Americans, nearly a third (32%) of consumers whose travel credit card came with a sign-up bonus spent more than they could afford to redeem the perk. "Sign-up bonuses are always primary motivators when it comes to consumers choosing and signing up for a new rewards card, which is why so many credit card issuers employ high bonuses to attract new business," said Sophia Mendel, travel expert at ValuePenguin.
Singapore-based crypto exchange Zipmex said on Sunday it’s in serious discussions with potential investors looking to buy the firm, days after halting all customer withdrawals citing market volatility and financial difficulty at some partners. See related article: Crypto exchange Zipmex freezes withdrawals Fast facts One of the interested parties has offered to start financial due […]
The electric car company also posted an impairment of $170 million on its remaining bitcoin holdings.
(Reuters) -Newmont Corp on Monday raised its annual cost forecast and warned that inflationary pressures would persist into 2023 after its second-quarter profit missed Street estimates, sending the world's biggest gold miner's shares down 12%. Higher operating costs related to labor, energy and supplies have forced the miner to hike its annual forecast for all-in sustaining costs (AISC), an industry metric that reflects total expenses, to $1,150 per ounce from $1,050 per ounce earlier. In comparison, the cost in the second quarter ended June 30 rose nearly 16% to $1,199 per ounce of gold.
Business confidence in Germany worsened sharply in July as firms turned more pessimistic due to rising energy costs and the threat of gas shortages.
McMahon, 76, who turned WWE into an entertainment powerhouse with more than $1 billion in annual revenue after buying the company from his father in 1982, stepped down on Friday as CEO and chairman. He is being investigated by WWE's board for agreements to pay $12 million over the past 16 years to suppress allegations of sexual misconduct and infidelity, the Wall Street Journal has reported. The exit, which several industry insiders considered inconceivable until a few days ago, saw his daughter Stephanie McMahon become the co-CEO along with Nick Khan.
China Evergrande Group, the world's most indebted developer, is expected to announce this week a debt restructuring plan that will not only determine its future but also indicate how Beijing plans to overcome a deepening property sector crisis. With more than $300 billion in debt, Evergrande has been at the centre of China's property quagmire since last year as the company struggled to repay suppliers, creditors, and investors in wealth management products after Beijing launched measures to control developers' high debt levels. The liquidity squeeze at Evergrande, whose entire $22.7 billion worth of offshore debt including loans and private bonds is deemed to be in default, subsequently engulfed other Chinese developers as their credit conditions deteriorated, and drove several smaller firms to defaults.
What to watch in markets on Monday, July 25, 2022.
Raymond James analyst Joshua Wilson lowered the price target on Avery Dennison Corp (NYSE: AVY) to $195 (an upside of 12.5%) from $200 while maintaining the Outperform rating on the shares. Ahead of calendar 2Q results, Wilson trimmed his estimates modestly for each covered name to account for FX mark-to-market. The analyst increased inflation headwinds where appropriate. The notable exception to this dynamic was polypropylene prices, which have fallen 10-15% since May. Wilson expects the contin
The past month has seen several changes take place at GameStop (GME). For one, the meme stock king announced a four-for-one stock split; on July 18, shareholders received three additional GME shares in the form of a stock dividend. Stock splits have become popular recently (everyone from Amazon to Tesla to Apple has been at it) and while they have no financial impact, they allow investors a lower entry point. Considering GME’s army of retail followers, this could be a move to appeal to its core
British Airways pilots poised to launch strike action Blow for Putin as China abandons investment in Russia The FTSE 100 rises 0.4pc Lucy Burton: The return of embittered former colleagues will poison office life Sign up here for our daily business briefing newsletter
Weber Inc on Monday replaced top boss Chris Scherzinger with an insider and warned that mounting inflationary and supply chain pressures could hit the grill maker's financials and workforce, sending its shares down 20% in premarket trading.
Devon Energy (DVN) could produce exceptional returns because of its solid growth attributes.
Sumitomo Mitsui Financial Group (SMBC Group), which runs one of Japan’s largest banks, said Friday it will work together with blockchain startup HashPort to develop non-fungible token (NFT) and Web3 projects. See related article: PSG sells US$220,000 NFT tickets for first Japan tour in 27 years Fast facts SMBC and HashPort plan to set up […]
Every one of those quarterly reports has shown a growing company, despite plenty of ups and downs in the economy—and the internet. Amazon’s worst quarter came in September 2001, when the internet bubble was blowing apart. Now, though, Amazon’s streak may be coming to an end.
The business growth outlook is slowing.
(Bloomberg) -- Most Read from BloombergSergey Brin Ordered Sale of Musk Investments After Affair: WSJVW Billionaire Clan Plotted CEO Ouster as He Was on US TripWho Is Nicole Shanahan, Woman at Center of Musk-Brin Drama?Fed to Inflict More Pain on Economy as It Readies Big Rate HikeChina’s Property Crisis Burns Middle Class Stuck With Huge LoansBarclays Plc is buying a stake in Copper, a cryptocurrency company that counts former Chancellor Philip Hammond among its advisers, according to Sky News.
Livent will help power GM's next generation of electric vehicles including the Chevrolet Blazer EV, Chevrolet Silverado EV, GMC Hummer EV and Cadillac Lyriq.
(Bloomberg) -- Coinbase Global Inc. is facing a US probe into whether it improperly let Americans trade digital assets that should have been registered as securities, according to three people familiar with the matter. The company’s shares dropped as much as 9.2%.Most Read from BloombergWho Is Nicole Shanahan, Woman at Center of Musk-Brin Drama?Trump Is Plotting to Blow Up the ConstitutionShallow Recession Calls Are ‘Totally Delusional,’ Roubini WarnsCoinbase Faces SEC Investigation on Cryptocur